Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

Mifepristone in Treating Patients With Recurrent or Persistent Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer

ClinicalTrials.gov ID: NCT00459290

Public ClinicalTrials.gov record NCT00459290. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 22, 2026, 5:11 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase II Evaluation of Mifepristone in the Treatment of Recurrent or Persistent Epithelial Ovarian or Primary Peritoneal Carcinoma

Study identification

NCT ID
NCT00459290
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Gynecologic Oncology Group
Network
Enrollment
24 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years to 120 Years
Sex
Female
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 30, 2007
Primary completion
Jun 30, 2010
Completion
Jun 30, 2010
Last update posted
Jul 17, 2018

2007 – 2010

United States locations

U.S. sites
22
U.S. states
15
U.S. cities
22
Facility City State ZIP Site status
Kaiser Permanente Medical Center - Los Angeles Los Angeles California 90027
Saint Francis/Mount Sinai Regional Cancer Center at Saint Francis Hospital and Medical Center Hartford Connecticut 06105
George Bray Cancer Center at the Hospital of Central Connecticut - New Britain Campus New Britain Connecticut 06050
Hinsdale Hematology Oncology Associates Hinsdale Illinois 60521
Woman's Hospital Baton Rouge Louisiana 70815
Maine Medical Center - Bramhall Campus Portland Maine 04102
Regional Cancer Center at Singing River Hospital Pascagoula Mississippi 39581
Freeman Cancer Institute at Freeman Health System Joplin Missouri 64804
Hulston Cancer Center at Cox Medical Center South Springfield Missouri 65807
Methodist Estabrook Cancer Center Omaha Nebraska 68114
Cancer Institute of New Jersey at Cooper - Voorhees Voorhees Township New Jersey 08043
Case Comprehensive Cancer Center Cleveland Ohio 44106-5065
Riverside Methodist Hospital Cancer Care Columbus Ohio 43214-3998
Lake/University Ireland Cancer Center Mentor Ohio 44060
Oklahoma University Cancer Institute Oklahoma City Oklahoma 73104
Rosenfeld Cancer Center at Abington Memorial Hospital Abington Pennsylvania 19001
Bryn Mawr Hospital Bryn Mawr Pennsylvania 19010
Cancer Center of Paoli Memorial Hospital Paoli Pennsylvania 19301-1792
Lankenau Cancer Center at Lankenau Hospital Wynnewood Pennsylvania 19096
Women and Infants Hospital of Rhode Island Providence Rhode Island 02905
University of Texas Medical Branch Galveston Texas 77555-0361
Marshfield Clinic - Marshfield Center Marshfield Wisconsin 54449

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00459290, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 17, 2018 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00459290 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →